The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
The antibody was designed and developed at Abzena’s Cambridge, UK,
The new CMC Process R&D Center represents a strategic investment in scale, sustainability, and specialization
Bioconjugation capability to complement commercial payload, linker, and monoclonal antibody services
Expanding US operations to address the increased demand for API development and manufacturing
In this role, Neeraj will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base
Subscribe To Our Newsletter & Stay Updated
